Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma

Yasuhiro Oki, Anas Younes, Javier Knickerbocker, Felipe Samaniego, Loretta Nastoupil, Fredrick Hagemeister, Jorge Romaguera, Nathan Fowler, Larry Kwak, Jason Westin

Research output: Contribution to journalLetterpeer-review

14 Scopus citations
Original languageEnglish (US)
Pages (from-to)e272-e274
JournalHaematologica
Volume100
Issue number7
DOIs
StatePublished - Jul 6 2015

Keywords

  • Clinical trial
  • Heat shock protein
  • Lymphoma
  • Targeted therapy

ASJC Scopus subject areas

  • Hematology

MD Anderson CCSG core facilities

  • Clinical and Translational Research Center
  • Clinical Trials Office

Cite this